69 related articles for article (PubMed ID: 21743150)
1. [Expression of Merlin protein in non-small cell lung carcinoma and the clinical significance].
Hu J; Wang L; Yu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):565-9. PubMed ID: 21743150
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of MAPK in non-small cell lung cancer].
Zhang ZF; Ma JQ; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
4. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
6. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
7. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Fu K; Zhang J
Chin Med J (Engl); 2008 Mar; 121(5):445-9. PubMed ID: 18364119
[TBL] [Abstract][Full Text] [Related]
8. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
Guo QS; Jia H; Han MY; Yu JM; Zhong WX
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Li L; Mei TH; Zhou XD; Zhang XG
Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
[TBL] [Abstract][Full Text] [Related]
14. [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance].
Zhang HZ; Hua P; Li HG; Lü ZQ; Zeng YJ; Liu JG; Zeng H
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):734-7. PubMed ID: 16483484
[TBL] [Abstract][Full Text] [Related]
15. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
16. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
18. [Expression of EYA2 in non-small cell lang cancer].
Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
[TBL] [Abstract][Full Text] [Related]
19. [AP-2 expression and significance in the lung cancer tissues].
Zhou R; Chen P; Zhang GS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):195-7. PubMed ID: 16145912
[TBL] [Abstract][Full Text] [Related]
20. [Expression of pSTAT3 in non-small cell lung cancer and its clinical significance].
Wang RJ; Zhang JZ; Wang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):288-90. PubMed ID: 22394639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]